Overexpression of Cyclin B1 Antagonizes Chemotherapeutic-Induced Apoptosis Through Pten/Akt Pathway in Human Esophageal Squamous Cell Carcinoma Cells

Yunwei Ou,Liying Ma,Ling Ma,Zhen Huang,Wei Zhou,Chunling Zhao,Bailin Zhang,Yongmei Song,Chunjiang Yu,Qimin Zhan
DOI: https://doi.org/10.4161/cbt.22627
2013-01-01
Cancer Biology & Therapy
Abstract:The role of cyclin B1 in the clinical therapeutic sensitivity of human esophageal squamous cell carcinoma (ESCC) remains to be defined. In this study, we found that elevated cyclin B1 expression attenuated the apoptosis induced by cisplatin or paclitaxel, while knockdown of cyclin B1 enhanced cisplatin or paclitaxel sensitivity in ESCC cells. Cyclin B1-mediated apoptosis may rely on the Bcl-2-dependent mitochondria-regulated intrinsic death pathway, and the antagonizing effect of cyclin B1 on chemotherapeutic agent-induced apoptosis was through PTEN/Akt pathway. Therefore, cyclin B1 might be a therapeutic target for the development of specific and efficient approaches in the treatment of ESCC.
What problem does this paper attempt to address?